FAKTOR OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - BOERSE MUENCHEN 15:45:28 2024-06-26 EDT | ||
| 15.27 EUR | -2.61% |
|
| Current month | -8.89% | ||
| 1 month | -7.27% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 15.27 | -2.61% |
| 24-06-25 | 15.68 | +0.26% |
| 24-06-24 | 15.64 | -3.75% |
| 24-06-21 | 16.25 | -5.19% |
| 24-06-20 | 17.14 | -0.35% |
Real-time BOERSE MUENCHEN
Last update June 26, 2024 at 03:45 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
UniCredit
|
| WKN | HD36D4 |
| ISIN | DE000HD36D45 |
| Date issued | 2024-02-28 |
| Strike | 56.25 $ |
| Maturity | Unlimited |
| Parity | 0.86 : 1 |
| Emission price | 10.34 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 18.49 € |
|---|---|
| Lowest since issue | 7.91 € |
| Spread | 0.02 € |
| Spread % | 0.13% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.19
USD
Average target price
53.19
USD
Spread / Average Target
+26.08%
- Stock Market
- Certificates
- Certificat
